1 Introduction The management of chronic refractory wounds following trauma or surgical procedures poses significant challenges in the clinic, imposing substantial social and economic burdens worldwide and severely compromising patients’ quality of life [1, 2]. Evidence indicates that persistent inflammation, caused by pathogen infection and overproduced reactive oxygen species (ROS), represents a critical barrier to the healing of chronic wounds for patients with diabetes [3-5].